Literature DB >> 27659524

Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.

Wenchen Gong1, Baocun Sun1,2,3, Xiulan Zhao1,2, Danfang Zhang1,2, Junying Sun1, Tieju Liu1,2, Qiang Gu1,2, Xueyi Dong1, Fang Liu1, Yong Wang1, Xian Lin1, Yanlei Li1.   

Abstract

Vasculogenic mimicry (VM) is a nonangiogenesis-dependent pathway that promotes tumor growth and disease progression. Nodal signaling has several vital roles in both embryo development and cancer progression. However, the effects of Nodal signaling on VM formation in breast cancer and its underlying mechanisms are ill-defined. We analyzed the relationship between Nodal signaling and VM formation in one hundred human breast cancer cases and the results showed that the expression of Nodal was significantly correlated with VM formation, tumor metastasis, differentiation grade, TNM stage and poor prognosis. Furthermore, up-regulation of Nodal expression promoted VM formation of breast cancer cells in vitro and in vivo. Knockdown of Nodal expression restrained VM formation. In addition, Nodal induced EMT and up-regulated the expression of Slug, Snail and c-Myc. We found that blocking the Smad2/3 pathway by administering SB431542 inhibited VM formation in breast cancer cell lines and xenografts. Taken together, Nodal signaling through the Smad2/3 pathway up-regulated Slug, Snail and c-Myc to induce EMT, thereby promoting VM formation. Our study suggests that the Nodal signaling pathway may serve as a therapeutic target to inhibit VM formation and improve prognosis in breast cancer patients.

Entities:  

Keywords:  EMT; Nodal signaling; Smad2/3 pathway; VM; breast cancer

Mesh:

Substances:

Year:  2016        PMID: 27659524      PMCID: PMC5342542          DOI: 10.18632/oncotarget.12161

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


  54 in total

Review 1.  Vasculogenic mimicry: current status and future prospects.

Authors:  Shiwu Zhang; Danfang Zhang; Baocun Sun
Journal:  Cancer Lett       Date:  2007-02-15       Impact factor: 8.679

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.

Authors:  Mitchell G Lawrence; Naira V Margaryan; Daniela Loessner; Angus Collins; Kris M Kerr; Megan Turner; Elisabeth A Seftor; Carson R Stephens; John Lai; Lynne-Marie Postovit; Judith A Clements; Mary J C Hendrix
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

4.  Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Jie Meng; Baocun Sun; Xiulan Zhao; Danfang Zhang; Xueming Zhao; Qiang Gu; Xueyi Dong; Nan Zhao; Peimei Liu; Yanrong Liu
Journal:  Mol Cancer Ther       Date:  2014-10-02       Impact factor: 6.261

5.  Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

Authors:  R E Seftor; E A Seftor; N Koshikawa; P S Meltzer; L M Gardner; M Bilban; W G Stetler-Stevenson; V Quaranta; M J Hendrix
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.

Authors:  Dueng-Yuan Hueng; Gu-Jiun Lin; Shing-Hwa Huang; Li-Wen Liu; Da-Tong Ju; Yuan-Wu Chen; Huey-Kang Sytwu; Chen Chang; Shih-Ming Huang; Yi-Shian Yeh; Horng-Mo Lee; Hsin-I Ma
Journal:  J Neurooncol       Date:  2010-11-30       Impact factor: 4.130

7.  CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.

Authors:  T J Liu; B C Sun; X L Zhao; X M Zhao; T Sun; Q Gu; Z Yao; X Y Dong; N Zhao; N Liu
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

8.  Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model.

Authors:  Lu-Xia Chen; Yan-Jin He; Shao-Zhen Zhao; Jian-Guo Wu; Jian-Tao Wang; Li-Min Zhu; Ting-Ting Lin; Bao-Cun Sun; Xiao-Rong Li
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

9.  The influence of different microenvironments on melanoma invasiveness and microcirculation patterns: an animal experiment study in the mouse model.

Authors:  Baocun Sun; Shiwu Zhang; Danfang Zhang; Yanjun Gu; Wenchao Zhang; Xiulan Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-16       Impact factor: 4.553

10.  Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.

Authors:  Enza Lonardo; Patrick C Hermann; Maria-Theresa Mueller; Stephan Huber; Anamaria Balic; Irene Miranda-Lorenzo; Sladjana Zagorac; Sonia Alcala; Iker Rodriguez-Arabaolaza; Juan Carlos Ramirez; Raul Torres-Ruíz; Elena Garcia; Manuel Hidalgo; David Álvaro Cebrián; Rainer Heuchel; Matthias Löhr; Frank Berger; Peter Bartenstein; Alexandra Aicher; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2011-11-04       Impact factor: 24.633

View more
  22 in total

1.  Nodal signaling activates the Smad2/3 pathway to regulate stem cell-like properties in breast cancer cells.

Authors:  Wenchen Gong; Baocun Sun; Huizhi Sun; Xiulan Zhao; Danfang Zhang; Tieju Liu; Nan Zhao; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.

Authors:  Abdulrahman Alwhaibi; Arti Verma; Sandeep Artham; Mir S Adil; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2019-06-14       Impact factor: 5.858

Review 3.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

Review 4.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

Review 5.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

Review 6.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

Review 7.  Cancer Stem Cells and Neovascularization.

Authors:  Fengkai Li; Jiahui Xu; Suling Liu
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

8.  Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer.

Authors:  Yanwei Shen; Jianfeng Quan; Mengying Wang; Shuting Li; Jiao Yang; Meng Lv; Zheling Chen; Lingxiao Zhang; Xiaoai Zhao; Jin Yang
Journal:  Oncotarget       Date:  2017-04-07

9.  Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.

Authors:  Cong Han; Baocun Sun; Xiulan Zhao; Yanhui Zhang; Qiang Gu; Fang Liu; Nan Zhao; Lili Wu
Journal:  Technol Cancer Res Treat       Date:  2017-11-22

Review 10.  Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?

Authors:  Heng Cai; Wenjing Liu; Xiaobai Liu; Zhiqing Li; Tianda Feng; Yixue Xue; Yunhui Liu
Journal:  Onco Targets Ther       Date:  2020-05-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.